Related Experiment Video
Updated: May 11, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: an update
1iMAH Hematology Associates, New Hyde Park, New York, NY 11040, USA. hmtsai@gmail.com
Abstract:
Since the last review in 2007 of thrombotic thrombocytopenic purpura (TTP) and microangiopathic hemolytic anemia in the Clinics, further understanding of the nature of TTP and atypical hemolytic uremic syndrome (aHUS) has led to increasing use of rituximab in the treatment of TTP and the approval in 2011 of eculizumab for the treatment of aHUS. With this new armamentarium, distinction of aHUS from TTP has become more critical than ever. This article updates the new knowledge, highlights the difference between aHUS and TTP, and presents a scheme for their diagnosis and management.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Venous Thrombosis III: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
